WFDC2 and kidney failure: Ten patients refused the proposed treatment; 3 patients died of non-oncological causes during the duration of the study; and 12 patients were excluded due to severe renal failure, elevated creatinine levels, and low GFR, which could affect the results of the HE4 marker.